Virtu KCG Holdings’s Apyx Medical APYX Stock Holding History

Virtu KCG Holdings’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$106K	Buy	42,941 +8,182	+24%	+$20.1K	﹤0.01%	2396
2017 Q1	$93K	Buy	34,759 +1,232	+4%	+$4.09K	﹤0.01%	2702
2016 Q4	$120K	Buy	33,527 +20,045	+149%	+$89.3K	﹤0.01%	2842
2016 Q3	$70K	Buy	+13,482	New	+$43.7K	﹤0.01%	2725
2016 Q2	–	Sell	-27,727	Closed	-$46K	–	2926
2016 Q1	$46K	Buy	27,727 +6,776	+32%	+$13.6K	﹤0.01%	2477
2015 Q4	$44K	Buy	+20,951	New	+$40.5K	﹤0.01%	3184
2015 Q2	–	Sell	-30,533	Closed	-$73K	–	3302
2015 Q1	$73K	Buy	+30,533	New	+$102K	﹤0.01%	2728
2014 Q3	–	Sell	-16,188	Closed	-$59K	–	3558
2014 Q2	$59K	Buy	+16,188	New	+$65.4K	﹤0.01%	3410
2014 Q1	–	Sell	-29,398	Closed	-$62K	–	3499
2013 Q4	$62K	Buy	+29,398	New	+$71.7K	﹤0.01%	3554

Other funds holding APYX

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Horizon Kinetics New York $3.06B AUM 5.37% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtu KCG Holdings's APYX Position: Q2 2017 in Review

Virtu KCG Holdings increased its Apyx Medical (APYX) stake by 24% in Q2 2017, buying an estimated $20.1K and bringing the position to 42,941 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #2396.

Virtu KCG Holdings first reported a position in APYX in Q4 2013 and has held it in 9 quarters since. The position peaked at $120K in Q4 2016. 39 funds tracked by Wall St. Rank hold APYX as of Q2 2017.

Virtu KCG Holdings held 42,941 shares of Apyx Medical worth $106K as of Q2 2017.
Virtu KCG Holdings bought 8,182 Apyx Medical shares in Q2 2017, an estimated $20.1K.
Apyx Medical made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2396 holding.
Virtu KCG Holdings first reported a position in Apyx Medical in Q4 2013 and has held it in 9 quarters since.
Virtu KCG Holdings's Apyx Medical position peaked at $120K in Q4 2016.
39 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.